Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

swissinfo.ch - swissinfo.ch - Lonza sells off its capsules division to British firm
Lonza sells off its capsules division to British firm
www.swissinfo.ch

Lonza will receive CHF1.7 billion in cash immediately and will retain a 40% stake in its capsules and health ingredients (CHI) business, with a preferential right on any future sale, the Basel-based pharma supplier said in a press release on…

yahoo.com - Ashar Jawad - Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast-Track AI-Driven Precision Medicine
Yahoo!

Tempus AI, Inc. (NASDAQ:TEM) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026. On March 3, the company announced a strategic partnership with Merck to fast-track the development of AI-driven precision medicine and support the…

indianexpress.com - Express News Service - Racket trafficking drugs disguised as aloe vera powder to Thailand, Malaysia through Mumbai busted, 1 held: Gujarat ATS
Racket trafficking drugs disguised as aloe vera powder to Thailand, Malaysia through Mumbai busted, 1 held: Gujarat ATS
The Indian Express

THE GUJARAT Anti-Terrorist Squad (ATS) on Saturday said it booked three Surat-based businessmen, who own five firms, through which they allegedly trafficked the anesthetic etomidate to Malaysia and Thailand by “mislabelling” it as…

thehindubusinessline.com - Bandu's Blockbusters For March 8, 2026
Bandu's Blockbusters For March 8, 2026
BusinessLine

On April 1, four years ago, piqued by the incessant jokes in the village at his expense, Bandu Barve decided he'd had enough. It was time for him to turn ‘smart'. His dead granny's voice rang in his ears — “Read the papers…

marketbeat.com - Promising Growth Stocks To Watch Now - March 7th
Promising Growth Stocks To Watch Now - March 7th
MarketBeat

3 Under-the-Radar AI Infrastructure Stocks Powering the Next Buildout Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of…

theguardian.com - Adrian Horton - 'A very paternalistic attitude': why is female desire still not taken seriously?
'A very paternalistic attitude': why is female desire still not taken seriously?
The Guardian

Barbara Gattuso had been happily married for decades when she signed up, in the late 2000s, for a clinical trial involving a potentially revolutionary new drug. She and her husband had once had a fulfilling sex life, both pre- and post-children.

marketbeat.com - 56,522 Shares in Amgen Inc. $AMGN Bought by Munich Reinsurance Co Stock Corp in Munich
56,522 Shares in Amgen Inc. $AMGN Bought by Munich Reinsurance Co Stock Corp in Munich
MarketBeat

Munich Reinsurance Co Stock Corp in Munich purchased a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund…

courant.com - The Associated Press - Starseeds, government plots and an alien mantis: Inside New Age spirituality's new age
Starseeds, government plots and an alien mantis: Inside New Age spirituality's new age
Hartford Courant

Getting your Trinity Audio player ready... LOS ANGELES (RNS) — “This ship was huge. It was like a city-sized ship. And there was hundreds of beings on board,” said Debbie Solaris, a military veteran and one of six panelists…

marketbeat.com - OPKO Health (NASDAQ:OPK) Downgraded to 'Sell' Rating by Wall Street Zen
OPKO Health (NASDAQ:OPK) Downgraded to 'Sell' Rating by Wall Street Zen
MarketBeat

OPKO Health (NASDAQ:OPK - Get Free Report) was downgraded by Wall Street Zen from a 'hold' rating to a 'sell' rating in a research report issued on Saturday. 3 Stocks That Wall Street Insiders Can't Stop Buying OPK has been the subject of several…

marketbeat.com - Wall Street Zen Upgrades Lantheus (NASDAQ:LNTH) to Strong-Buy
Wall Street Zen Upgrades Lantheus (NASDAQ:LNTH) to Strong-Buy
MarketBeat

Lantheus (NASDAQ:LNTH - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'hold' rating to a 'strong-buy' rating in a report released on Saturday. Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn't Ignore A number…

marketbeat.com - Munich Reinsurance Co Stock Corp in Munich Invests $47.60 Million in AbbVie Inc. $ABBV
Munich Reinsurance Co Stock Corp in Munich Invests $47.60 Million in AbbVie Inc. $ABBV
MarketBeat

Munich Reinsurance Co Stock Corp in Munich purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased…

marketbeat.com - Vanguard Group Inc. Sells 618,758 Shares of Fortrea Holdings Inc. $FTRE
Vanguard Group Inc. Sells 618,758 Shares of Fortrea Holdings Inc. $FTRE
MarketBeat

Vanguard Group Inc. decreased its position in Fortrea Holdings Inc. (NASDAQ:FTRE - Free Report) by 7.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…

marketbeat.com - Munich Reinsurance Co Stock Corp in Munich Invests $18.97 Million in Cencora, Inc. $COR
Munich Reinsurance Co Stock Corp in Munich Invests $18.97 Million in Cencora, Inc. $COR
MarketBeat

Munich Reinsurance Co Stock Corp in Munich bought a new stake in shares of Cencora, Inc. (NYSE:COR - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund…

marketbeat.com - Krystal Biotech, Inc. $KRYS Position Trimmed by GW&K Investment Management LLC
Krystal Biotech, Inc. $KRYS Position Trimmed by GW&K Investment Management LLC
MarketBeat

GW&K Investment Management LLC trimmed its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 65.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional…

marketbeat.com - 2,440 Shares in Vertex Pharmaceuticals Incorporated $VRTX Purchased by Legacy Capital Group California Inc.
2,440 Shares in Vertex Pharmaceuticals Incorporated $VRTX Purchased by Legacy Capital Group California Inc.
MarketBeat

Legacy Capital Group California Inc. acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange…

Receive a Daily briefing on Pharma Industry News

Get Started